These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 | ||||
|
|
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 | ||||
|
|
|
||||
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | ||||
|
|
|||||
|
|
|||||
| (Address of principal executive offices) (Zip Code) | |||||
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
|
|
|
|
||||||
|
|
☒
|
Accelerated filer | ☐ | ||||||||
| Non-accelerated filer | ☐ | Smaller reporting company |
|
||||||||
| Emerging growth company |
|
||||||||||
| Page | |||||
| June 30, 2025 | December 31, 2024 | |||||||||||||
| Assets | ||||||||||||||
| Current assets: | ||||||||||||||
| Cash and cash equivalents | $ |
|
$ |
|
||||||||||
| Receivables, net |
|
|
||||||||||||
| Inventories |
|
|
||||||||||||
| Prepaid expenses and other current assets |
|
|
||||||||||||
| Total current assets |
|
|
||||||||||||
| Property, plant, and equipment, net |
|
|
||||||||||||
| Operating lease right-of-use assets |
|
|
||||||||||||
| Goodwill |
|
|
||||||||||||
| Intangible assets, net |
|
|
||||||||||||
| Other assets, net |
|
|
||||||||||||
| Total assets | $ |
|
$ |
|
||||||||||
| Liabilities and Stockholders' Equity | ||||||||||||||
| Current liabilities: | ||||||||||||||
| Accounts payable | $ |
|
$ |
|
||||||||||
| Accrued expenses |
|
|
||||||||||||
| Current portion of long-term debt |
|
|
||||||||||||
| Total current liabilities |
|
|
||||||||||||
| Long-term debt |
|
|
||||||||||||
| Operating lease liabilities |
|
|
||||||||||||
| Deferred income taxes |
|
|
||||||||||||
| Other long-term liabilities |
|
|
||||||||||||
| Total liabilities |
|
|
||||||||||||
|
Commitments and contingencies (Note 16)
|
|
|
||||||||||||
| Stockholders' equity: | ||||||||||||||
|
Preferred stock, par value $
|
|
|
||||||||||||
|
Common stock, par value $
|
|
|
||||||||||||
| Treasury stock |
(
|
(
|
||||||||||||
| Additional paid-in capital |
|
|
||||||||||||
| Accumulated deficit |
(
|
(
|
||||||||||||
| Accumulated other comprehensive loss |
(
|
(
|
||||||||||||
| Total stockholders' equity |
|
|
||||||||||||
| Total liabilities and stockholders' equity | $ |
|
$ |
|
||||||||||
|
Three Months Ended
June 30, |
Six Months Ended
June 30, |
|||||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||||||
| Net sales | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Cost of sales |
|
|
|
|
||||||||||||||||||||||
| Gross profit |
|
|
|
|
||||||||||||||||||||||
| Operating expenses: | ||||||||||||||||||||||||||
| Selling and distribution |
|
|
|
|
||||||||||||||||||||||
| General and administrative |
|
|
|
|
||||||||||||||||||||||
| Amortization expense |
|
|
|
|
||||||||||||||||||||||
| Asset impairment |
|
|
|
|
||||||||||||||||||||||
| Other operating expense, net |
|
|
|
|
||||||||||||||||||||||
| Total operating expenses |
|
|
|
|
||||||||||||||||||||||
| Operating income (loss) |
|
(
|
|
(
|
||||||||||||||||||||||
| Other expense: | ||||||||||||||||||||||||||
| Interest expense |
|
|
|
|
||||||||||||||||||||||
| Interest income |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Loss on extinguishment of debt |
|
|
|
|
||||||||||||||||||||||
| (Gain) loss on foreign currency exchange |
(
|
|
(
|
|
||||||||||||||||||||||
| Other expense (income), net |
|
(
|
|
(
|
||||||||||||||||||||||
| Total other expense |
|
|
|
|
||||||||||||||||||||||
| Loss before income taxes |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Income tax benefit |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Net loss | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||
| Earnings (loss) per common share: | ||||||||||||||||||||||||||
| Basic | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||
| Diluted |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Weighted average common shares: | ||||||||||||||||||||||||||
| Basic |
|
|
|
|
||||||||||||||||||||||
| Diluted |
|
|
|
|
||||||||||||||||||||||
|
Three Months Ended
June 30, |
Six Months Ended
June 30, |
|||||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||||||
| Net loss | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||
| Other comprehensive income (loss): | ||||||||||||||||||||||||||
| Foreign currency translation adjustments |
|
(
|
|
(
|
||||||||||||||||||||||
| Pension and postretirement reclassification adjustment |
(
|
|
(
|
|
||||||||||||||||||||||
| Other comprehensive income (loss) |
|
(
|
|
(
|
||||||||||||||||||||||
| Comprehensive income (loss) | $ |
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||
| Accumulated | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Additional | Other | |||||||||||||||||||||||||||||||||||||||||||||||||
| Common Stock | Treasury Stock | Paid-In | Accumulated | Comprehensive | Total | |||||||||||||||||||||||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | Capital | Deficit | Loss | Equity | |||||||||||||||||||||||||||||||||||||||||||
| Balance, January 1, 2024 |
|
$ |
|
(
|
$ |
(
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
||||||||||||||||||||||||||||||||||||
| Net loss | — | — | — | — | — |
(
|
— |
(
|
||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive loss | — | — | — | — | — | — |
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||
| Treasury stock repurchases | — | — |
(
|
(
|
— | — | — |
(
|
||||||||||||||||||||||||||||||||||||||||||
| Issuance of stock awards |
|
— | — | — |
(
|
— | — |
(
|
||||||||||||||||||||||||||||||||||||||||||
| Stock-based compensation | — | — | — | — |
|
— | — |
|
||||||||||||||||||||||||||||||||||||||||||
| Balance, March 31, 2024 |
|
$ |
|
(
|
$ |
(
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
||||||||||||||||||||||||||||||||||||
| Net loss | — | — | — | — | — |
(
|
— |
(
|
||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive loss | — | — | — | — | — | — |
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||
| Treasury stock repurchases | — | — |
(
|
(
|
— | — | — |
(
|
||||||||||||||||||||||||||||||||||||||||||
| Issuance of stock awards | — | — | — | — |
(
|
— | — |
(
|
||||||||||||||||||||||||||||||||||||||||||
| Stock-based compensation | — | — | — | — |
|
— | — |
|
||||||||||||||||||||||||||||||||||||||||||
| Balance, June 30, 2024 |
|
$ |
|
(
|
$ |
(
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
||||||||||||||||||||||||||||||||||||
| Balance, January 1, 2025 |
|
$ |
|
(
|
$ |
(
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
||||||||||||||||||||||||||||||||||||
| Net loss | — | — | — | — | — |
(
|
— |
(
|
||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive income | — | — | — | — | — | — |
|
|
||||||||||||||||||||||||||||||||||||||||||
| Issuance of stock awards |
|
— | — | — |
(
|
— | — |
(
|
||||||||||||||||||||||||||||||||||||||||||
| Stock-based compensation | — | — | — | — |
|
— | — |
|
||||||||||||||||||||||||||||||||||||||||||
| Balance, March 31, 2025 |
|
$ |
|
(
|
$ |
(
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
||||||||||||||||||||||||||||||||||||
| Net loss | — | — | — | — | — |
(
|
— |
(
|
||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive income | — | — | — | — | — | — |
|
|
||||||||||||||||||||||||||||||||||||||||||
| Issuance of stock awards |
|
— | — | — |
(
|
— | — |
(
|
||||||||||||||||||||||||||||||||||||||||||
| Stock-based compensation | — | — | — | — |
|
— | — |
|
||||||||||||||||||||||||||||||||||||||||||
| Balance, June 30, 2025 |
|
$ |
|
(
|
$ |
(
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
||||||||||||||||||||||||||||||||||||
|
Six Months Ended
June 30, |
||||||||||||||
| 2025 | 2024 | |||||||||||||
| Cash flows from operating activities: | ||||||||||||||
| Net loss | $ |
(
|
$ |
(
|
||||||||||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||||||||
| Depreciation and amortization |
|
|
||||||||||||
| Asset impairment |
|
|
||||||||||||
| Stock-based compensation |
|
|
||||||||||||
| Loss on extinguishment of debt |
|
|
||||||||||||
| Unrealized loss (gain) on derivative contracts |
|
(
|
||||||||||||
| Other, net |
(
|
|
||||||||||||
| Changes in operating assets and liabilities, net of acquisitions: | ||||||||||||||
| Receivables |
(
|
(
|
||||||||||||
| Inventories |
(
|
(
|
||||||||||||
| Prepaid expenses and other assets |
(
|
(
|
||||||||||||
| Accounts payable |
(
|
(
|
||||||||||||
| Accrued expenses and other liabilities |
|
(
|
||||||||||||
| Net cash used in operating activities |
(
|
(
|
||||||||||||
| Cash flows from investing activities: | ||||||||||||||
| Capital expenditures |
(
|
(
|
||||||||||||
| Proceeds from sales of fixed assets |
|
|
||||||||||||
| Acquisition, net of cash acquired |
(
|
|
||||||||||||
| Net cash used in investing activities |
(
|
(
|
||||||||||||
| Cash flows from financing activities: | ||||||||||||||
| Borrowings under Revolving Credit Facility |
|
|
||||||||||||
| Payments under Revolving Credit Facility |
(
|
(
|
||||||||||||
| Payments on financing lease obligations |
(
|
(
|
||||||||||||
| Payment of deferred financing costs |
(
|
|
||||||||||||
| Payments on Term Loans |
(
|
|
||||||||||||
| Proceeds from refinanced Term Loans |
|
|
||||||||||||
| Repurchases of common stock |
|
(
|
||||||||||||
| Payments related to stock-based award activities |
(
|
(
|
||||||||||||
| Net cash provided by (used in) financing activities |
|
(
|
||||||||||||
| Effect of exchange rate changes on cash and cash equivalents |
(
|
(
|
||||||||||||
| Net decrease in cash and cash equivalents |
(
|
(
|
||||||||||||
| Cash and cash equivalents, beginning of period |
|
|
||||||||||||
| Cash and cash equivalents, end of period | $ |
|
$ |
|
||||||||||
|
Six Months Ended
June 30, |
||||||||||||||
| 2025 | 2024 | |||||||||||||
| Supplemental cash flow disclosures: | ||||||||||||||
| Interest paid | $ |
|
$ |
|
||||||||||
| Net income taxes paid |
|
|
||||||||||||
| Non-cash investing and financing activities: | ||||||||||||||
| Capital expenditures incurred but not yet paid |
|
|
||||||||||||
| Right-of-use assets obtained in exchange for lease obligations |
|
|
||||||||||||
| Preliminary purchase price adjustment for private brand tea business acquisition |
|
|
||||||||||||
| Accrued deferred financing costs |
|
|
||||||||||||
|
Three Months Ended
June 30, |
Six Months Ended
June 30, |
|||||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||||||
| (In millions) | ||||||||||||||||||||||||||
| Cost of sales | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Other operating expense, net |
|
|
|
|
||||||||||||||||||||||
| Total | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
|
Three Months Ended
June 30, |
Six Months Ended
June 30, |
|||||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||||||
| (In millions) | ||||||||||||||||||||||||||
| Employee-related | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Other costs |
|
|
|
|
||||||||||||||||||||||
| Asset-related |
|
|
|
|
||||||||||||||||||||||
| Total | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Severance | ||||||||||||||||||||||||||
| (In millions) | ||||||||||||||||||||||||||
| Balance as of December 31, 2024 | $ |
|
||||||||||||||||||||||||
| Expenses recognized |
|
|||||||||||||||||||||||||
| Cash payments |
(
|
|||||||||||||||||||||||||
| Balance as of June 30, 2025 | $ |
|
||||||||||||||||||||||||
| June 30, 2025 | December 31, 2024 | |||||||||||||
| (In millions) | ||||||||||||||
| Outstanding accounts receivable sold | $ |
|
$ |
|
||||||||||
| Receivables collected and not remitted to financial institution |
|
|
||||||||||||
| Six Months Ended June 30, | ||||||||||||||
| 2025 | 2024 | |||||||||||||
| (In millions) | ||||||||||||||
| Receivables sold | $ |
|
$ |
|
||||||||||
| Receivables collected and remitted to financial institution |
(
|
(
|
||||||||||||
| June 30, 2025 | December 31, 2024 | |||||||||||||
| (In millions) | ||||||||||||||
| Raw materials and supplies | $ |
|
$ |
|
||||||||||
| Finished goods |
|
|
||||||||||||
| Total inventories | $ |
|
$ |
|
||||||||||
| (In millions) | |||||
|
Cash transferred at close
|
$ |
|
|||
|
Preliminary purchase price adjustment
|
(
|
||||
| Total consideration transferred | $ |
|
|||
|
Allocation of consideration to assets acquired and liabilities assumed:
|
|||||
|
Cash
|
$ |
|
|||
|
Receivables
|
|
||||
| Inventories |
|
||||
|
Property, plant, and equipment
|
|
||||
|
Operating lease right-of-use assets
|
|
||||
| Goodwill |
|
||||
| Customer relationships |
|
||||
|
Trademarks
|
|
||||
| Other assets |
|
||||
| Assets acquired |
|
||||
| Assumed liabilities |
(
|
||||
| Total purchase price | $ |
|
|||
| Three Months Ended June 30, 2024 | Six Months Ended June 30, 2024 | |||||||||||||
| (Unaudited, in millions) | ||||||||||||||
|
Pro forma net sales
|
$ |
|
$ |
|
||||||||||
|
Pro forma net loss
|
(
|
(
|
||||||||||||
| (In millions) | |||||
| Cash transferred at close | $ |
|
|||
| Purchase price adjustment |
|
||||
| Total consideration transferred | $ |
|
|||
| Allocation of consideration to assets acquired: | |||||
| Inventories | $ |
|
|||
| Trademarks |
|
||||
| Total purchase price | $ |
|
|||
| June 30, 2025 | December 31, 2024 | |||||||||||||
| (In millions) | ||||||||||||||
| Land | $ |
|
$ |
|
||||||||||
| Buildings and improvements |
|
|
||||||||||||
| Machinery and equipment |
|
|
||||||||||||
| Construction in progress |
|
|
||||||||||||
| Total |
|
|
||||||||||||
| Less accumulated depreciation |
(
|
(
|
||||||||||||
| Property, plant, and equipment, net | $ |
|
$ |
|
||||||||||
| Goodwill | ||||||||
| (In millions) | ||||||||
| Balance at December 31, 2024 | $ |
|
||||||
| Foreign currency exchange adjustments |
|
|||||||
| Acquisition |
|
|||||||
| Balance at June 30, 2025 | $ |
|
||||||
| June 30, 2025 | December 31, 2024 | ||||||||||||||||||||||||||||||||||||||||
|
Gross
Carrying Amount |
Accumulated
Amortization |
Net
Carrying Amount |
Gross
Carrying Amount |
Accumulated
Amortization |
Net
Carrying Amount |
||||||||||||||||||||||||||||||||||||
| (In millions) | |||||||||||||||||||||||||||||||||||||||||
| Intangible assets with finite lives: | |||||||||||||||||||||||||||||||||||||||||
| Customer-related | $ |
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||||
| Trademarks |
|
(
|
|
|
(
|
|
|||||||||||||||||||||||||||||||||||
| Formulas/recipes |
|
(
|
|
|
(
|
|
|||||||||||||||||||||||||||||||||||
| Computer software |
|
(
|
|
|
(
|
|
|||||||||||||||||||||||||||||||||||
| Total finite lived intangibles |
|
(
|
|
|
(
|
|
|||||||||||||||||||||||||||||||||||
| Intangible assets with indefinite lives: | |||||||||||||||||||||||||||||||||||||||||
| Trademarks |
|
— |
|
|
— |
|
|||||||||||||||||||||||||||||||||||
| Total intangible assets | $ |
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||||
| June 30, 2025 | December 31, 2024 | |||||||||||||
| (In millions) | ||||||||||||||
| Revolving Credit Facility | $ |
|
$ |
|
||||||||||
| Term Loan A |
|
|
||||||||||||
| Term Loan A-1 |
|
|
||||||||||||
| 2028 Notes |
|
|
||||||||||||
| Finance leases |
|
|
||||||||||||
| Total outstanding debt |
|
|
||||||||||||
| Deferred financing costs |
(
|
(
|
||||||||||||
| Less current portion |
(
|
(
|
||||||||||||
| Total long-term debt | $ |
|
$ |
|
||||||||||
| Remainder of 2025 | $ |
|
|||
| 2026 |
|
||||
| 2027 |
|
||||
| 2028 |
|
||||
| 2029 |
|
||||
| Thereafter |
|
||||
| Total outstanding debt | $ |
|
|||
|
Three Months Ended
June 30, |
Six Months Ended
June 30, |
|||||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||||||
| (In millions, except per share data) | ||||||||||||||||||||||||||
| Shares repurchased |
|
|
|
|
||||||||||||||||||||||
| Weighted average price per share | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Total cost | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Excise tax (1) | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
|
Three Months Ended
June 30, |
Six Months Ended
June 30, |
|||||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||||||
| (In millions) | ||||||||||||||||||||||||||
| Weighted average common shares outstanding |
|
|
|
|
||||||||||||||||||||||
| Assumed exercise/vesting of equity awards (1) |
|
|
|
|
||||||||||||||||||||||
| Weighted average diluted common shares outstanding |
|
|
|
|
||||||||||||||||||||||
|
Three Months Ended
June 30, |
Six Months Ended
June 30, |
|||||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||||||
| (In millions) | (In millions) | |||||||||||||||||||||||||
| Compensation expense related to stock-based payments | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Related income tax benefit |
|
|
|
|
||||||||||||||||||||||
|
Employee
Options |
Weighted
Average Exercise Price |
Weighted
Average Remaining Contractual Term (yrs.) |
Aggregate
Intrinsic Value |
|||||||||||||||||||||||
| (In thousands) | (In millions) | |||||||||||||||||||||||||
| Outstanding, at December 31, 2024 |
|
$ |
|
|
$ |
|
||||||||||||||||||||
| Expired |
(
|
|
||||||||||||||||||||||||
| Outstanding, at June 30, 2025 |
|
|
|
|
||||||||||||||||||||||
| Exercisable, at June 30, 2025 |
|
|
|
|
||||||||||||||||||||||
|
Employee
Restricted Stock Units |
Weighted
Average Grant Date Fair Value |
Non-Employee Director
Restricted
Stock Units
|
Weighted
Average Grant Date Fair Value |
|||||||||||||||||||||||
| (In thousands) | (In thousands) | |||||||||||||||||||||||||
| Nonvested, at December 31, 2024 |
|
$ |
|
|
$ |
|
||||||||||||||||||||
| Granted |
|
|
|
|
||||||||||||||||||||||
| Vested |
(
|
|
(
|
|
||||||||||||||||||||||
| Forfeited |
(
|
|
|
|
||||||||||||||||||||||
| Nonvested, at June 30, 2025 |
|
|
|
|
||||||||||||||||||||||
| Earned and deferred, at June 30, 2025 |
|
|
||||||||||||||||||||||||
|
Three Months Ended
June 30, |
Six Months Ended
June 30, |
|||||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||||||
| (In millions) | (In millions) | |||||||||||||||||||||||||
| Fair value of vested restricted stock units | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Tax benefit recognized from vested restricted stock units |
|
|
|
|
||||||||||||||||||||||
|
Six Months Ended
June 30, |
||||||||||||||
| 2025 | ||||||||||||||
| Dividend yield |
|
% | ||||||||||||
| Risk-free rate |
|
% | ||||||||||||
| Expected volatility (TreeHouse Foods, Inc.) |
|
% | ||||||||||||
| Expected volatility (Peer Group) |
|
% | ||||||||||||
| Expected term (in years) |
|
|||||||||||||
|
Performance
Units |
Weighted
Average Grant Date Fair Value |
|||||||||||||
| (In thousands) | ||||||||||||||
| Nonvested, at December 31, 2024 |
|
$ |
|
|||||||||||
| Granted |
|
|
||||||||||||
| Vested |
(
|
|
||||||||||||
| Forfeited |
(
|
|
||||||||||||
| Nonvested, at June 30, 2025 |
|
|
||||||||||||
|
Three Months Ended
June 30, |
Six Months Ended
June 30, |
|||||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||||||
| (In millions) | (In millions) | |||||||||||||||||||||||||
| Fair value of vested performance units | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Tax benefit recognized from performance units vested |
|
|
|
|
||||||||||||||||||||||
|
Foreign
Currency Translation (1) |
Unrecognized
Pension and Postretirement Benefits (1) |
Accumulated
Other Comprehensive Loss |
||||||||||||||||||
| (In millions) | ||||||||||||||||||||
| Balance at December 31, 2023 | $ |
(
|
$ |
|
$ |
(
|
||||||||||||||
| Other comprehensive loss |
(
|
|
(
|
|||||||||||||||||
| Balance at June 30, 2024 | $ |
(
|
$ |
|
$ |
(
|
||||||||||||||
| Balance at December 31, 2024 | $ |
(
|
$ |
|
$ |
(
|
||||||||||||||
|
Other comprehensive income before reclassifications
|
|
|
|
|||||||||||||||||
| Reclassifications from accumulated other comprehensive loss (2) |
|
(
|
(
|
|||||||||||||||||
|
Other comprehensive income (loss)
|
|
(
|
|
|||||||||||||||||
| Balance at June 30, 2025 | $ |
(
|
$ |
|
$ |
(
|
||||||||||||||
|
Three Months Ended
June 30, |
Six Months Ended
June 30, |
|||||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||||||
| (In millions) | (In millions) | |||||||||||||||||||||||||
| Service cost | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Interest cost |
|
|
|
|
||||||||||||||||||||||
| Expected return on plan assets |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Amortization of unrecognized net loss |
|
|
|
|
||||||||||||||||||||||
|
Net periodic pension (benefit) cost
|
$ |
(
|
$ |
|
$ |
(
|
$ |
|
||||||||||||||||||
|
Three Months Ended
June 30, |
Six Months Ended
June 30, |
|||||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||||||
| (In millions) | (In millions) | |||||||||||||||||||||||||
| Interest cost | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Amortization of unrecognized net gain |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Net periodic postretirement cost | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Balance Sheet Location | June 30, 2025 | December 31, 2024 | ||||||||||||||||||
| (In millions) | ||||||||||||||||||||
| Asset derivatives | ||||||||||||||||||||
| Commodity contracts | Prepaid expenses and other current assets | $ |
|
$ |
|
|||||||||||||||
| Interest rate swap agreements | Prepaid expenses and other current assets |
|
|
|||||||||||||||||
| Interest rate swap agreements | Other assets, net |
|
|
|||||||||||||||||
| $ |
|
$ |
|
|||||||||||||||||
| Liability derivatives | ||||||||||||||||||||
| Commodity contracts | Accrued expenses | $ |
|
$ |
|
|||||||||||||||
| Interest rate swap agreements | Accrued expenses |
|
|
|||||||||||||||||
| $ |
|
$ |
|
|||||||||||||||||
|
Location of (Loss) Gain
|
Three Months Ended
June 30, |
Six Months Ended
June 30, |
||||||||||||||||||||||||||||||
|
Recognized in Net Loss
|
2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||||||||||
| (In millions) | (In millions) | |||||||||||||||||||||||||||||||
|
Mark-to-market unrealized (loss) gain
|
||||||||||||||||||||||||||||||||
| Commodity contracts | Other expense (income), net | $ |
(
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||||||||||
| Interest rate swap agreements | Other expense (income), net |
(
|
(
|
(
|
|
|||||||||||||||||||||||||||
|
Total unrealized (loss) gain
|
$ |
(
|
$ |
|
$ |
(
|
$ |
|
||||||||||||||||||||||||
|
Realized (loss) gain
|
||||||||||||||||||||||||||||||||
| Commodity contracts |
Manufacturing-related to Cost of sales and transportation-related to Selling and distribution
|
$ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||
| Interest rate swap agreements | Interest expense |
|
|
|
|
|||||||||||||||||||||||||||
|
Total realized gain
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||
|
Total (loss) gain
|
$ |
(
|
$ |
|
$ |
(
|
$ |
|
||||||||||||||||||||||||
|
Three Months Ended
June 30, |
Six Months Ended
June 30, |
||||||||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||||||||
| (In millions) | (In millions) | ||||||||||||||||||||||||||||
| Net sales | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||
| Cost of sales |
|
|
|
|
|||||||||||||||||||||||||
| Selling, distribution, general, and administrative: | |||||||||||||||||||||||||||||
| Freight out and commissions |
|
|
|
|
|||||||||||||||||||||||||
| Direct selling, general, and administrative |
|
|
|
|
|||||||||||||||||||||||||
| Corporate selling, general, and administrative |
|
|
|
|
|||||||||||||||||||||||||
| Amortization expense |
|
|
|
|
|||||||||||||||||||||||||
| Asset impairment |
|
|
|
|
|||||||||||||||||||||||||
| Other operating expense, net | (1) |
|
|
|
|
||||||||||||||||||||||||
| Total other expense | (2) |
|
|
|
|
||||||||||||||||||||||||
| Income tax benefit |
(
|
(
|
(
|
(
|
|||||||||||||||||||||||||
| Net loss | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||||||||
| Product Category Group | Principal Products | |||||||
| Snacking | Candy; cookies; crackers; in-store bakery items; pretzels; and frozen griddle items | |||||||
| Beverages & drink mixes | Broths/stocks; non-dairy creamer; powdered beverages and other blends; ready-to-drink beverages (production ceased in the first quarter of 2025); coffee; and tea | |||||||
| Grocery | Cheese & pudding; hot cereal; pickles; and refrigerated dough | |||||||
|
Three Months Ended
June 30, |
Six Months Ended
June 30, |
|||||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||||||
| (In millions) | (In millions) | |||||||||||||||||||||||||
| Snacking | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Beverages & drink mixes |
|
|
|
|
||||||||||||||||||||||
| Grocery |
|
|
|
|
||||||||||||||||||||||
| Total net sales | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
|
Three Months Ended
June 30, |
Six Months Ended
June 30, |
|||||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||||||
| (In millions) | (In millions) | |||||||||||||||||||||||||
| Retail grocery | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Co-manufacturing |
|
|
|
|
||||||||||||||||||||||
| Food-away-from-home and other |
|
|
|
|
||||||||||||||||||||||
| Total net sales | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Three Months Ended June 30, | ||||||||||||||||||||||||||||||||||||||
| 2025 | 2024 | Increase / (Decrease) | ||||||||||||||||||||||||||||||||||||
|
(Dollars in millions, except per share amounts)
|
Dollars | Percent | Dollars | Percent | $ Change | % Change | ||||||||||||||||||||||||||||||||
| Net sales | $ | 798.0 | 100.0 | % | $ | 788.5 | 100.0 | % | $ | 9.5 | 1.2 | % | ||||||||||||||||||||||||||
| Cost of sales | 658.8 | 82.6 | 660.2 | 83.7 | (1.4) | (0.2) | ||||||||||||||||||||||||||||||||
| Gross profit | 139.2 | 17.4 | 128.3 | 16.3 | 10.9 | 8.5 | ||||||||||||||||||||||||||||||||
| Operating expenses: | ||||||||||||||||||||||||||||||||||||||
| Selling and distribution | 35.0 | 4.4 | 35.5 | 4.5 | (0.5) | (1.4) | ||||||||||||||||||||||||||||||||
| General and administrative | 51.3 | 6.4 | 54.2 | 6.9 | (2.9) | (5.4) | ||||||||||||||||||||||||||||||||
| Amortization expense | 13.2 | 1.7 | 12.1 | 1.5 | 1.1 | 9.1 | ||||||||||||||||||||||||||||||||
| Asset impairment | — | — | 19.3 | 2.4 | (19.3) | (100.0) | ||||||||||||||||||||||||||||||||
| Other operating expense, net | 12.4 | 1.6 | 11.2 | 1.4 | 1.2 | 10.7 | ||||||||||||||||||||||||||||||||
| Total operating expenses | 111.9 | 14.1 | 132.3 | 16.7 | (20.4) | (15.4) | ||||||||||||||||||||||||||||||||
| Operating income (loss) | 27.3 | 3.3 | (4.0) | (0.4) | 31.3 | 782.5 | ||||||||||||||||||||||||||||||||
| Other expense: | ||||||||||||||||||||||||||||||||||||||
| Interest expense | 22.2 | 2.8 | 15.6 | 2.0 | 6.6 | 42.3 | ||||||||||||||||||||||||||||||||
| Interest income | (0.2) | — | (0.1) | — | (0.1) | (100.0) | ||||||||||||||||||||||||||||||||
| (Gain) loss on foreign currency exchange | (4.7) | (0.6) | 1.5 | 0.2 | (6.2) | (413.3) | ||||||||||||||||||||||||||||||||
| Other expense (income), net | 15.6 | 2.0 | (0.1) | — | 15.7 | 15,700.0 | ||||||||||||||||||||||||||||||||
| Total other expense | 32.9 | 4.2 | 16.9 | 2.2 | 16.0 | 94.7 | ||||||||||||||||||||||||||||||||
| Loss before income taxes | (5.6) | (0.9) | (20.9) | (2.6) | 15.3 | 73.2 | ||||||||||||||||||||||||||||||||
| Income tax benefit | (2.7) | (0.3) | (4.2) | (0.5) | 1.5 | 35.7 | ||||||||||||||||||||||||||||||||
| Net loss | $ | (2.9) | (0.6) | % | $ | (16.7) | (2.1) | % | $ | 13.8 | 82.6 | % | ||||||||||||||||||||||||||
| Earnings (loss) per common share: | ||||||||||||||||||||||||||||||||||||||
| Basic | $ | (0.06) | $ | (0.32) | $ | 0.26 | 81.3 | % | ||||||||||||||||||||||||||||||
| Diluted | (0.06) | (0.32) | 0.26 | 81.3 | ||||||||||||||||||||||||||||||||||
| Three Months Ended June 30, | |||||||||||||||||||||||
| 2025 | 2024 | Increase / (Decrease) | |||||||||||||||||||||
|
(Dollars in millions, except per share amounts)
|
Dollars | Dollars |
$ Change
|
% Change
|
|||||||||||||||||||
|
Other financial data:
(1)
|
|||||||||||||||||||||||
| EBITDA | $ | 58.5 | $ | 30.8 | $ | 27.7 | 89.9 | % | |||||||||||||||
| Adjusted EBITDA | 73.3 | 70.6 | 2.7 | 3.8 | |||||||||||||||||||
|
Adjusted net sales
|
801.4 | 789.9 | 11.5 | 1.4 | |||||||||||||||||||
|
Adjusted cost of sales
|
668.7 | 653.9 | 14.8 | 2.3 | |||||||||||||||||||
| Adjusted gross profit | 132.7 | 136.0 | (3.3) | (2.4) | |||||||||||||||||||
| Adjusted total operating expenses | 98.7 | 99.8 | (1.1) | (1.1) | |||||||||||||||||||
|
Adjusted operating income
|
34.0 | 36.2 | (2.2) | (6.1) | |||||||||||||||||||
|
Adjusted total other expense
|
21.9 | 17.3 | 4.6 | 26.6 | |||||||||||||||||||
|
Adjusted income tax expense
|
3.3 | 3.9 | (0.6) | (15.4) | |||||||||||||||||||
|
Adjusted net income
|
8.8 | 15.0 | (6.2) | (41.3) | |||||||||||||||||||
|
Adjusted diluted earnings (loss) per share
|
$ | 0.17 | $ | 0.29 | $ | (0.12) | (41.4) | % | |||||||||||||||
| Dollars | Percent | |||||||||||||
| (In millions) | ||||||||||||||
| Margin management | $ | (20.5) | (2.6) | % | ||||||||||
| Consumption/other | (19.1) | (2.4) | ||||||||||||
| Griddle recall service impacts | (9.7) | (1.2) | ||||||||||||
| Volume/mix | $ | (49.3) | (6.2) | % | ||||||||||
| Business acquisition | 35.5 | 4.5 | ||||||||||||
| Pricing | 33.5 | 4.2 | ||||||||||||
| Business exit | (7.8) | (1.0) | ||||||||||||
| Product recall returns | (1.8) | (0.2) | ||||||||||||
| Foreign currency | (0.6) | (0.1) | ||||||||||||
| Total change in net sales | $ | 9.5 | 1.2 | % | ||||||||||
| Product recall returns/other | 2.0 | 0.2 | ||||||||||||
| Total change in adjusted net sales (1) | $ | 11.5 | 1.4 | % | ||||||||||
|
The net sales increase of 1.2% was primarily due to the acquisition of the private brand tea business, favorable pricing to recover commodity inflation, and distribution gains. This was partially offset by volume/mix related to planned margin management actions, broader macroeconomic consumption trends, service impacts related to the voluntary recall of frozen griddle products, and the RTD business exit.
|
||
|
Gross Profit
— Gross profit as a percentage of net sales was 17.4% in the second quarter of 2025, compared to 16.3% in the second quarter of 2024, an increase of 1.1 percentage points. The increase is primarily due to $13.1 million of insurance recoveries related to voluntary product recalls received during the second quarter of 2025, favorable margin from the Harris Tea acquisition and supply chain savings initiatives. This was partially offset by commodity cost inflation and unfavorable fixed cost absorption due to declining consumption trends.
|
||
|
Total Operating Expenses
— Total operating expenses were $111.9 million in the second quarter of 2025 compared to $132.3 million in the second quarter of 2024, a decrease of $20.4 million. The decrease in expense is primarily due to a non-cash impairment charge recorded in the second quarter of 2024 of $19.3 million related to the Ready-to-drink beverages asset group, as well as cost reduction activities in 2025.
|
||
|
Total Other Expense
—
Total other expense was $32.9 million in the second quarter of 2025 compared to $16.9 million in the second quarter of 2024, an increase in expense of $16.0 million. The increase was due to a $16.2 million unfavorable change in non-cash mark-to-market impacts from hedging activities, driven by commodity contracts, primarily coffee, and interest rate swaps. Additionally, the Company had an increase of $6.6 million in interest expense primarily due to an increase in borrowings on our Revolving Credit Facility. This was partially offset by a favorable currency exchange rate impact of $6.2 million between the U.S. and Canada.
|
||
|
Income Taxes
— Income taxes were recognized at an effective rate of 48.2% in the second quarter of 2025 compared to 20.1% recognized in the second quarter of 2024. The change in the Company’s effective tax rate is primarily driven by changes in the amounts of executive compensation that is not deductible for tax purposes and the estimated amount of annual pre-tax earnings.
|
||
| Our effective tax rate may change from period to period based on recurring and non-recurring factors including the jurisdictional mix of earnings, enacted tax legislation, state income taxes, settlement of tax audits, and the expiration of the statute of limitations in relation to unrecognized tax benefits. | ||
| Six Months Ended June 30, | ||||||||||||||||||||||||||||||||||||||
| 2025 | 2024 | Increase / (Decrease) | ||||||||||||||||||||||||||||||||||||
|
(Dollars in millions, except per share amounts)
|
Dollars | Percent | Dollars | Percent | $ Change | % Change | ||||||||||||||||||||||||||||||||
| Net sales | $ | 1,590.0 | 100.0 | % | $ | 1,609.2 | 100.0 | % | $ | (19.2) | (1.2) | % | ||||||||||||||||||||||||||
| Cost of sales | 1,335.6 | 84.0 | 1,368.9 | 85.1 | (33.3) | (2.4) | ||||||||||||||||||||||||||||||||
| Gross profit | 254.4 | 16.0 | 240.3 | 14.9 | 14.1 | 5.9 | ||||||||||||||||||||||||||||||||
| Operating expenses: | ||||||||||||||||||||||||||||||||||||||
| Selling and distribution | 71.4 | 4.5 | 78.4 | 4.9 | (7.0) | (8.9) | ||||||||||||||||||||||||||||||||
| General and administrative | 107.0 | 6.7 | 110.0 | 6.8 | (3.0) | (2.7) | ||||||||||||||||||||||||||||||||
| Amortization expense | 26.3 | 1.7 | 24.2 | 1.5 | 2.1 | 8.7 | ||||||||||||||||||||||||||||||||
| Asset impairment | — | — | 19.3 | 1.2 | (19.3) | (100.0) | ||||||||||||||||||||||||||||||||
| Other operating expense, net | 27.9 | 1.8 | 17.6 | 1.1 | 10.3 | 58.5 | ||||||||||||||||||||||||||||||||
| Total operating expenses | 232.6 | 14.7 | 249.5 | 15.5 | (16.9) | (6.8) | ||||||||||||||||||||||||||||||||
| Operating income (loss) | 21.8 | 1.3 | (9.2) | (0.6) | 31.0 | 337.0 | ||||||||||||||||||||||||||||||||
| Other expense: | ||||||||||||||||||||||||||||||||||||||
| Interest expense | 41.5 | 2.6 | 31.2 | 1.9 | 10.3 | 33.0 | ||||||||||||||||||||||||||||||||
| Interest income | (3.0) | (0.2) | (4.1) | (0.3) | 1.1 | 26.8 | ||||||||||||||||||||||||||||||||
| Loss on extinguishment of debt | 2.6 | 0.2 | — | — | 2.6 | 100.0 | ||||||||||||||||||||||||||||||||
|
(Gain) loss on foreign currency exchange
|
(5.0) | (0.3) | 4.9 | 0.3 | (9.9) | (202.0) | ||||||||||||||||||||||||||||||||
| Other expense (income), net | 34.9 | 2.2 | (5.0) | (0.3) | 39.9 | 798.0 | ||||||||||||||||||||||||||||||||
| Total other expense | 71.0 | 4.5 | 27.0 | 1.6 | 44.0 | 163.0 | ||||||||||||||||||||||||||||||||
|
Loss before income taxes
|
(49.2) | (3.2) | (36.2) | (2.2) | (13.0) | (35.9) | ||||||||||||||||||||||||||||||||
|
Income tax benefit
|
(14.5) | (0.9) | (7.8) | (0.5) | (6.7) | (85.9) | ||||||||||||||||||||||||||||||||
|
Net loss
|
$ | (34.7) | (2.3) | % | $ | (28.4) | (1.7) | % | $ | (6.3) | (22.2) | % | ||||||||||||||||||||||||||
| Earnings (loss) per common share: | ||||||||||||||||||||||||||||||||||||||
| Basic | $ | (0.69) | $ | (0.54) | $ | (0.15) | (27.8) | % | ||||||||||||||||||||||||||||||
| Diluted | (0.69) | (0.54) | (0.15) | (27.8) | ||||||||||||||||||||||||||||||||||
| Six Months Ended June 30, | |||||||||||||||||||||||
| 2025 | 2024 | Increase / (Decrease) | |||||||||||||||||||||
|
(Dollars in millions, except per share amounts)
|
Dollars | Dollars |
$ Change
|
% Change
|
|||||||||||||||||||
|
Other financial data:
(1)
|
|||||||||||||||||||||||
| EBITDA | $ | 72.8 | $ | 63.7 | $ | 9.1 | 14.3 | % | |||||||||||||||
| Adjusted EBITDA | 130.8 | 116.6 | 14.2 | 12.2 | |||||||||||||||||||
|
Adjusted net sales
|
1,597.4 | 1,611.5 | (14.1) | (0.9) | |||||||||||||||||||
|
Adjusted cost of sales
|
1,340.9 | 1,354.7 | (13.8) | (1.0) | |||||||||||||||||||
| Adjusted gross profit | 256.5 | 256.8 | (0.3) | (0.1) | |||||||||||||||||||
| Adjusted total operating expenses | 201.3 | 208.1 | (6.8) | (3.3) | |||||||||||||||||||
|
Adjusted operating income
|
55.2 | 48.7 | 6.5 | 13.3 | |||||||||||||||||||
|
Adjusted total other expense
|
40.6 | 32.0 | 8.6 | 26.9 | |||||||||||||||||||
| Adjusted income tax expense | 4.3 | 3.5 | 0.8 | 22.9 | |||||||||||||||||||
| Adjusted net income | 10.3 | 13.2 | (2.9) | (22.0) | |||||||||||||||||||
| Adjusted diluted earnings (loss) per share | $ | 0.20 | $ | 0.25 | $ | (0.05) | (20.0) | % | |||||||||||||||
| Dollars | Percent | |||||||||||||
| (In millions) | ||||||||||||||
| Margin management | $ | (47.2) | (2.9) | % | ||||||||||
| Consumption/other | (41.1) | (2.6) | ||||||||||||
| Griddle recall service impacts | (29.1) | (1.8) | ||||||||||||
| Volume/mix | $ | (117.4) | (7.3) | % | ||||||||||
| Business acquisition | 74.1 | 4.6 | ||||||||||||
| Pricing | 42.2 | 2.6 | ||||||||||||
| Business exit | (10.9) | (0.7) | ||||||||||||
| Product recall returns | (4.6) | (0.3) | ||||||||||||
| Foreign currency | (2.6) | (0.1) | ||||||||||||
| Total change in net sales | $ | (19.2) | (1.2) | % | ||||||||||
| Product recall returns/other | 5.1 | 0.3 | ||||||||||||
| Total change in adjusted net sales (1) | $ | (14.1) | (0.9) | % | ||||||||||
|
Six Months Ended
June 30, |
||||||||||||||
| 2025 | 2024 | |||||||||||||
| (In millions) | ||||||||||||||
|
Net Cash Flows (Used In) Provided By:
|
||||||||||||||
| Operating activities | $ | (100.7) | $ | (71.8) | ||||||||||
| Investing activities | (258.5) | (49.7) | ||||||||||||
| Financing activities | 89.2 | (92.9) | ||||||||||||
|
Net cash used in operating activities was $100.7 million in the first six months of 2025 compared to $71.8 million in the first six months of 2024, an increase in cash used of $28.9 million, which was primarily attributable to a decrease in cash flows from the Receivables Sales Program. Refer to Note 4 to our Condensed Consolidated Financial Statements for additional information regarding the Receivables Sales Program. This was partially offset by higher cash earnings reflecting the Company's pricing actions to recover commodity inflation.
|
||
|
Net cash used in investing activities was $258.5 million in the first six months of 2025 compared to $49.7 million in the first six months of 2024, an increase in cash used of $208.8 million. The increase in cash used for investing activities in the first six months of 2025 was primarily driven by the $209.3 million of cash used for the acquisition of the private brand tea business in the first quarter of 2025. This was partially offset by proceeds of $4.8 million which were primarily from the sale of machinery and equipment related to the RTD business exit.
|
||
|
Net cash provided by financing activities was $89.2 million in the first six months of 2025 compared to $92.9 million net cash used in financing activities in the first six months of 2024, an increase in cash provided of $182.1 million. The increase in cash provided is primarily due to cash inflows from the Revolving Credit Facility of $105.0 million in the first six months of 2025 and $88.7 million of non-recurring common stock repurchases during the first six months of 2024. This was partially offset by costs related to the debt refinancing that occurred in January 2025.
|
||
| TreeHouse Foods, Inc. and Guarantor Subsidiaries | ||||||||
| Summarized Statement of Operations | Six Months Ended June 30, 2025 | |||||||
| (Unaudited, in millions) | ||||||||
| Net sales | $ | 1,546.0 | ||||||
| Gross profit (1) | 254.8 | |||||||
| Net loss | (28.8) | |||||||
| TreeHouse Foods, Inc. and Guarantor Subsidiaries | ||||||||||||||
| Summarized Balance Sheet | June 30, 2025 | December 31, 2024 | ||||||||||||
| (Unaudited, in millions) | ||||||||||||||
| Current assets | $ | 817.2 | $ | 926.8 | ||||||||||
| Noncurrent assets | 2,925.4 | 2,782.9 | ||||||||||||
| Current liabilities | 662.2 | 676.5 | ||||||||||||
| Noncurrent liabilities (2) | 1,699.2 | 1,629.9 | ||||||||||||
| Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||||||
| (unaudited, in millions) | ||||||||||||||||||||||||||
| Net loss (GAAP) | $ | (2.9) | $ | (16.7) | $ | (34.7) | $ | (28.4) | ||||||||||||||||||
| Interest expense | 22.2 | 15.6 | 41.5 | 31.2 | ||||||||||||||||||||||
| Interest income | (0.2) | (0.1) | (3.0) | (4.1) | ||||||||||||||||||||||
| Income tax benefit | (2.7) | (4.2) | (14.5) | (7.8) | ||||||||||||||||||||||
| Depreciation and amortization | 42.1 | 36.2 | 83.5 | 72.8 | ||||||||||||||||||||||
| EBITDA (Non-GAAP) | 58.5 | 30.8 | 72.8 | 63.7 | ||||||||||||||||||||||
|
Mark-to-market adjustments
(1)
|
14.7 | (1.5) | 31.7 | (8.5) | ||||||||||||||||||||||
|
Restructuring programs & other, excluding accelerated depreciation
(2)
|
12.7 | 11.5 | 28.1 | 18.2 | ||||||||||||||||||||||
|
Acquisition, integration, divestiture, and related costs
(3)
|
0.7 | 1.9 | 3.2 | 6.0 | ||||||||||||||||||||||
|
Foreign currency (gain) loss on re-measurement of intercompany notes
(4)
|
(3.7) | 1.1 | (3.9) | 3.5 | ||||||||||||||||||||||
|
Product recalls and related (income) costs, including insurance recoveries
(5)
|
(9.6) | 7.5 | (3.7) | 14.4 | ||||||||||||||||||||||
|
Loss on extinguishment of debt
(6)
|
— | — | 2.6 | — | ||||||||||||||||||||||
|
Impairment
(7)
|
— | 19.3 | — | 19.3 | ||||||||||||||||||||||
| Adjusted EBITDA (Non-GAAP) | $ | 73.3 | $ | 70.6 | $ | 130.8 | $ | 116.6 | ||||||||||||||||||
| % of net sales | ||||||||||||||||||||||||||
| Net loss margin | (0.4) | % | (2.1) | % | (2.2) | % | (1.8) | % | ||||||||||||||||||
| EBITDA margin | 7.3 | % | 3.9 | % | 4.6 | % | 4.0 | % | ||||||||||||||||||
| % of adjusted net sales | ||||||||||||||||||||||||||
| Adjusted EBITDA margin | 9.1 | % | 8.9 | % | 8.2 | % | 7.2 | % | ||||||||||||||||||
| (1) |
The Company's derivative contracts are marked-to-market each period. The non-cash unrealized changes in fair value recognized in Other expense (income), net within the Condensed Consolidated Statements of Operations are treated as Non-GAAP adjustments. As the contracts are settled, realized gains and losses are recognized, and only the mark-to-market impacts are treated as Non-GAAP adjustments.
|
||||
|
Refer to Note 17 to our Condensed Consolidated Financial Statements for additional information.
|
|||||
| (2) |
The Company's restructuring and margin improvement activities are part of an enterprise-wide transformation to improve the long-term profitability of the Company. During the three and six months ended June 30, 2025, the Company recognized $2.9 million and $5.8 million, respectively, of accelerated depreciation within the Company's restructuring activities as depreciation expense. There was no accelerated depreciation recognized during the three and six months ended June 30, 2024.
|
||||
|
Refer to Note 3 to our Condensed Consolidated Financial Statements for additional information.
|
|||||
| (3) |
Acquisition, integration, divestiture, and related costs represents costs associated with completed and potential acquisitions, the related integration of the acquisitions, completed and potential divestitures, and gains or losses on the divestiture of a business. During the three and six months ended June 30, 2025, $0.5 million and $0.8 million were classified in General and administrative and $0.2 million and $0.5 million were classified in Net sales, respectively. Additionally, $1.9 million was classified in Cost of sales during the six months ended June 30, 2025. During the three and six months ended June 30, 2024, $1.7 million and $3.7 million were classified in General and administrative and $0.2 million and $2.1 million were classified in Cost of sales, respectively. Additionally, $0.2 million was classified in Other operating expense, net during the six months ended June 30, 2024.
|
||||
|
Refer to Note 6 to our Condensed Consolidated Financial Statements for additional information.
|
|||||
| (4) | The Company has foreign currency denominated intercompany loans and incurred foreign currency gains/losses to re-measure the loans at quarter end. These amounts are non-cash and the loans are eliminated in consolidation. | ||||
| (5) |
Griddle Recall and Related (Income) Costs, including Insurance Recoveries
On October 18, 2024, the Company initiated a voluntary recall of certain frozen waffle products produced at its Brantford, Ontario, Canada facility, and on October 22, 2024, the Company expanded its voluntary recall to include all products manufactured at the Brantford facility that are still within their shelf-life. For the three and six months ended June 30, 2025, the Non-GAAP adjustments included an insurance recovery of $(10.0) million in each period and $3.4 million and $9.2 million for estimated product returns and claims, respectively.
Broth Recall and Related (Income) Costs, including Insurance Recoveries
On September 22, 2023, the Company initiated a voluntary recall of certain broth products produced at its Cambridge, Maryland facility and executed a turnaround plan to restore the facility operations. For the three and six months ended June 30, 2025, the Non-GAAP adjustments included an insurance recovery of $(3.1) million in each period and other costs of $0.1 million and $0.2 million, respectively.
For the three and six months ended June 30, 2024, the Non-GAAP adjustments included non-cash plant shutdown charges of $4.5 million and $8.9 million, non-cash inventory write-offs of $0.3 million and $2.6 million, and other costs, including product returns and logistics, of $2.7 million and $2.9 million, respectively.
|
||||
|
Refer to Note 16 to our Condensed Consolidated Financial Statements for additional information.
|
|||||
| (6) |
During the first quarter of 2025, the Company incurred a loss on extinguishment of debt, which included a write off of deferred financing costs of $2.6 million in connection with the Credit Agreement refinancing.
|
||||
|
Refer to Note 10 to our Condensed Consolidated Financial Statements for additional information.
|
|||||
| (7) |
During the second quarter of 2024, the Company incurred $19.3 million of non-cash impairment charges related to property, plant, and equipment. The impairment is due to forecasted cash flow losses in the Ready-to-drink beverages business resulting in a decision to exit this business.
|
||||
|
Refer to Note 7 to our Condensed Consolidated Financial Statements for additional information.
|
|||||
| Three Months Ended June 30, 2025 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| (Unaudited, in millions, except per share amounts) | Net sales | Cost of sales | Gross profit | Total operating expenses | Operating income | Total other expense | Income tax (benefit) expense | Net (loss) income | ||||||||||||||||||||||||||||||||||||||||||
| As reported (GAAP) | $ | 798.0 | $ | 658.8 | $ | 139.2 | $ | 111.9 | $ | 27.3 | $ | 32.9 | $ | (2.7) | $ | (2.9) | ||||||||||||||||||||||||||||||||||
| Adjustments: | ||||||||||||||||||||||||||||||||||||||||||||||||||
|
Mark-to-market adjustments
(1)
|
— | — | — | — | — | (14.7) | — | 14.7 | ||||||||||||||||||||||||||||||||||||||||||
|
Restructuring programs & other, including accelerated depreciation
(2)
|
— | (2.9) | 2.9 | (12.7) | 15.6 | — | — | 15.6 | ||||||||||||||||||||||||||||||||||||||||||
|
Acquisition, integration, divestiture, and related costs
(3)
|
0.2 | — | 0.2 | (0.5) | 0.7 | — | — | 0.7 | ||||||||||||||||||||||||||||||||||||||||||
|
Foreign currency gain on re-measurement of intercompany notes
(4)
|
— | — | — | — | — | 3.7 | — | (3.7) | ||||||||||||||||||||||||||||||||||||||||||
|
Product recalls and related (income) costs, including insurance recoveries
(5)
|
3.2 | 12.8 | (9.6) | — | (9.6) | — | — | (9.6) | ||||||||||||||||||||||||||||||||||||||||||
| Taxes on adjusting items | — | — | — | — | — | — | 6.0 | (6.0) | ||||||||||||||||||||||||||||||||||||||||||
| As adjusted (Non-GAAP) | $ | 801.4 | $ | 668.7 | $ | 132.7 | $ | 98.7 | $ | 34.0 | $ | 21.9 | $ | 3.3 | $ | 8.8 | ||||||||||||||||||||||||||||||||||
| As reported (% of net sales) | 17.4 | % | 14.0 | % | 3.4 | % | 4.1 | % | (0.3) | % | (0.4) | % | ||||||||||||||||||||||||||||||||||||||
| As adjusted (% of adjusted net sales) | 16.6 | % | 12.3 | % | 4.2 | % | 2.7 | % | 0.4 | % | 1.1 | % | ||||||||||||||||||||||||||||||||||||||
| Earnings (loss) per share: | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Diluted | $ | (0.06) | ||||||||||||||||||||||||||||||||||||||||||||||||
| Adjusted diluted | $ | 0.17 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Weighted average common shares: | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Diluted for net loss | 50.5 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Diluted for adjusted net income | 50.6 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Three Months Ended June 30, 2024 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| (Unaudited, in millions, except per share amounts) | Net sales | Cost of sales | Gross profit | Total operating expenses | Operating (loss) income | Total other expense | Income tax (benefit) expense | Net (loss) income | ||||||||||||||||||||||||||||||||||||||||||
| As reported (GAAP) | $ | 788.5 | $ | 660.2 | $ | 128.3 | $ | 132.3 | $ | (4.0) | $ | 16.9 | $ | (4.2) | $ | (16.7) | ||||||||||||||||||||||||||||||||||
| Adjustments: | ||||||||||||||||||||||||||||||||||||||||||||||||||
|
Mark-to-market adjustments
(1)
|
— | — | — | — | — | 1.5 | — | (1.5) | ||||||||||||||||||||||||||||||||||||||||||
|
Restructuring programs & other
(2)
|
— | — | — | (11.5) | 11.5 | — | — | 11.5 | ||||||||||||||||||||||||||||||||||||||||||
|
Acquisition, integration, divestiture, and related costs
(3)
|
— | (0.2) | 0.2 | (1.7) | 1.9 | — | — | 1.9 | ||||||||||||||||||||||||||||||||||||||||||
|
Foreign currency loss on re-measurement of intercompany notes
(4)
|
— | — | — | — | — | (1.1) | — | 1.1 | ||||||||||||||||||||||||||||||||||||||||||
|
Product recalls and related costs
(5)
|
1.4 | (6.1) | 7.5 | — | 7.5 | — | — | 7.5 | ||||||||||||||||||||||||||||||||||||||||||
|
Impairment
(7)
|
— | — | — | (19.3) | 19.3 | — | — | 19.3 | ||||||||||||||||||||||||||||||||||||||||||
| Taxes on adjusting items | — | — | — | — | — | — | 8.1 | (8.1) | ||||||||||||||||||||||||||||||||||||||||||
| As adjusted (Non-GAAP) | $ | 789.9 | $ | 653.9 | $ | 136.0 | $ | 99.8 | $ | 36.2 | $ | 17.3 | $ | 3.9 | $ | 15.0 | ||||||||||||||||||||||||||||||||||
| As reported (% of net sales) | 16.3 | % | 16.8 | % | (0.5) | % | 2.1 | % | (0.5) | % | (2.1) | % | ||||||||||||||||||||||||||||||||||||||
| As adjusted (% of adjusted net sales) | 17.2 | % | 12.6 | % | 4.6 | % | 2.2 | % | 0.5 | % | 1.9 | % | ||||||||||||||||||||||||||||||||||||||
| Earnings (loss) per share | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Diluted | $ | (0.32) | ||||||||||||||||||||||||||||||||||||||||||||||||
| Adjusted diluted | $ | 0.29 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Weighted average common shares: | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Diluted for net loss | 52.3 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Diluted for adjusted net income | 52.5 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Six Months Ended June 30, 2025 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| (Unaudited, in millions, except per share amounts) | Net sales | Cost of sales | Gross profit | Total operating expenses | Operating income | Total other expense | Income tax (benefit) expense | Net (loss) income | ||||||||||||||||||||||||||||||||||||||||||
| As reported (GAAP) | $ | 1,590.0 | $ | 1,335.6 | $ | 254.4 | $ | 232.6 | $ | 21.8 | $ | 71.0 | $ | (14.5) | $ | (34.7) | ||||||||||||||||||||||||||||||||||
| Adjustments: | ||||||||||||||||||||||||||||||||||||||||||||||||||
|
Mark-to-market adjustments
(1)
|
— | — | — | — | — | (31.7) | — | 31.7 | ||||||||||||||||||||||||||||||||||||||||||
|
Restructuring programs & other, including accelerated depreciation
(2)
|
— | (5.7) | 5.7 | (28.2) | 33.9 | — | — | 33.9 | ||||||||||||||||||||||||||||||||||||||||||
|
Acquisition, integration, divestiture, and related costs
(3)
|
0.5 | (1.9) | 2.4 | (0.8) | 3.2 | — | — | 3.2 | ||||||||||||||||||||||||||||||||||||||||||
|
Foreign currency gain on re-measurement of intercompany notes
(4)
|
— | — | — | — | — | 3.9 | — | (3.9) | ||||||||||||||||||||||||||||||||||||||||||
|
Product recalls and related (income) costs, including insurance recoveries
(5)
|
6.9 | 12.9 | (6.0) | (2.3) | (3.7) | — | — | (3.7) | ||||||||||||||||||||||||||||||||||||||||||
|
Loss on extinguishment of debt
(6)
|
— | — | — | — | — | (2.6) | — | 2.6 | ||||||||||||||||||||||||||||||||||||||||||
| Taxes on adjusting items | — | — | — | — | — | — | 18.8 | (18.8) | ||||||||||||||||||||||||||||||||||||||||||
| As adjusted (Non-GAAP) | $ | 1,597.4 | $ | 1,340.9 | $ | 256.5 | $ | 201.3 | $ | 55.2 | $ | 40.6 | $ | 4.3 | $ | 10.3 | ||||||||||||||||||||||||||||||||||
| As reported (% of net sales) | 16.0 | % | 14.6 | % | 1.4 | % | 4.5 | % | (0.9) | % | (2.2) | % | ||||||||||||||||||||||||||||||||||||||
| As adjusted (% of adjusted net sales) | 16.1 | % | 12.6 | % | 3.5 | % | 2.5 | % | 0.3 | % | 0.6 | % | ||||||||||||||||||||||||||||||||||||||
| Earnings (loss) per share: | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Diluted | $ | (0.69) | ||||||||||||||||||||||||||||||||||||||||||||||||
| Adjusted diluted | $ | 0.20 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Weighted average common shares: | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Diluted for net loss | 50.5 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Diluted for adjusted net income | 50.5 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Six Months Ended June 30, 2024 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| (Unaudited, in millions, except per share amounts) | Net sales | Cost of sales | Gross profit | Total operating expenses | Operating (loss) income | Total other expense | Income tax (benefit) expense | Net (loss) income | ||||||||||||||||||||||||||||||||||||||||||
| As reported (GAAP) | $ | 1,609.2 | $ | 1,368.9 | $ | 240.3 | $ | 249.5 | $ | (9.2) | $ | 27.0 | $ | (7.8) | $ | (28.4) | ||||||||||||||||||||||||||||||||||
| Adjustments: | ||||||||||||||||||||||||||||||||||||||||||||||||||
|
Mark-to-market adjustments
(1)
|
— | — | — | — | — | 8.5 | — | (8.5) | ||||||||||||||||||||||||||||||||||||||||||
|
Restructuring programs & other
(2)
|
— | — | — | (18.2) | 18.2 | — | — | 18.2 | ||||||||||||||||||||||||||||||||||||||||||
|
Acquisition, integration, divestiture, and related costs
(3)
|
— | (2.1) | 2.1 | (3.9) | 6.0 | — | — | 6.0 | ||||||||||||||||||||||||||||||||||||||||||
|
Foreign currency loss on re-measurement of intercompany notes
(4)
|
— | — | — | — | — | (3.5) | — | 3.5 | ||||||||||||||||||||||||||||||||||||||||||
|
Product recalls and related costs
(5)
|
2.3 | (12.1) | 14.4 | — | 14.4 | — | — | 14.4 | ||||||||||||||||||||||||||||||||||||||||||
|
Impairment
(7)
|
— | — | — | (19.3) | 19.3 | — | — | 19.3 | ||||||||||||||||||||||||||||||||||||||||||
| Taxes on adjusting items | — | — | — | — | — | — | 11.3 | (11.3) | ||||||||||||||||||||||||||||||||||||||||||
| As adjusted (Non-GAAP) | $ | 1,611.5 | $ | 1,354.7 | $ | 256.8 | $ | 208.1 | $ | 48.7 | $ | 32.0 | $ | 3.5 | $ | 13.2 | ||||||||||||||||||||||||||||||||||
| As reported (% of net sales) | 14.9 | % | 15.5 | % | (0.6) | % | 1.7 | % | (0.5) | % | (1.8) | % | ||||||||||||||||||||||||||||||||||||||
| As adjusted (% of adjusted net sales) | 15.9 | % | 12.9 | % | 3.0 | % | 2.0 | % | 0.2 | % | 0.8 | % | ||||||||||||||||||||||||||||||||||||||
| Earnings per share: | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Diluted | $ | (0.54) | ||||||||||||||||||||||||||||||||||||||||||||||||
| Adjusted diluted | $ | 0.25 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Weighted average common shares: | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Diluted for net loss | 53.0 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Diluted for adjusted net income | 53.4 | |||||||||||||||||||||||||||||||||||||||||||||||||
|
Six Months Ended
June 30, |
||||||||||||||
| 2025 | 2024 | |||||||||||||
| (In millions) | ||||||||||||||
|
Cash flow used in operating activities (GAAP)
|
$ | (100.7) | $ | (71.8) | ||||||||||
|
Capital expenditures
|
(54.0) | (51.1) | ||||||||||||
| Proceeds from sales of fixed assets | 4.8 | 1.4 | ||||||||||||
|
Free cash flow (Non-GAAP)
|
$ | (149.9) | $ | (121.5) | ||||||||||
| 3.1 | |||||
| 3.2 | |||||
| 22* | |||||
| 31.1* | |||||
| 31.2* | |||||
| 32.1* | |||||
| 32.2* | |||||
| 101.INS* | Inline XBRL Instance Document. | ||||
| 101.SCH* | Inline XBRL Taxonomy Extension Schema Document. | ||||
| 101.CAL* | Inline XBRL Taxonomy Extension Calculation Linkbase Document. | ||||
| 101.LAB* | Inline XBRL Taxonomy Extension Label Linkbase Document. | ||||
| 101.PRE* | Inline XBRL Taxonomy Extension Presentation Linkbase Document. | ||||
| 101.DEF* | Inline XBRL Taxonomy Extension Definition Linkbase Document. | ||||
| 104* |
The cover page from TreeHouse Foods, Inc.'s Quarterly Report on Form 10-Q for the quarter ended June 30, 2025, formatted in Inline XBRL (included as Exhibit 101).
|
||||
| TREEHOUSE FOODS, INC. | |||||
|
Date: July 31, 2025
|
/s/ Patrick M. O'Donnell | ||||
| Patrick M. O'Donnell | |||||
| Executive Vice President and Chief Financial Officer | |||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
Customers
| Customer name | Ticker |
|---|---|
| Tyson Foods, Inc. | TSN |
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|